Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cord Blood MNCs for Bone Marrow Failure After Chemotherapy in Children
NCT05628272Unknown
- Sponsor
- Shandong Provincial Qianfoshan Hospital
- Start
- Oct 2022
- Primary completion
- Sep 2024
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Randomised, open-label trial of ASD + CB-MNC in bone marrow failure, sponsored by Shandong Provincial Qianfoshan Hospital. Primary endpoint: recovery time of peripheral neutrophils at 20 days. Status: unknown.
02
Drugs
ASD + CB-MNC
03
Conditions
bone marrow failure
Beyond the preview
Go deeper on NCT05628272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05628272.